
19955111
{19955111:RCD6PV69}
1
vancouver
50
default
4930
https://neuropediatoolkit.org/wp-content/plugins/zotpress/
statussuccessupdateneededfalseinstancefalsemetarequest_last0request_next0used_cachetruedatakeyRCD6PV69libraryid19955111metacreatorSummaryMcTagueetal.parsedDate2016-03-01numChildren1bibltdivclassquotcsl-bib-bodyquotstylequotline-height1.35quotgtnltdivclassquotcsl-entryquotstylequotclearleftquotgtnltdivclassquotcsl-left-marginquotstylequotfloatleftpadding-right0.5emtext-alignrightwidth1emquotgt1.ltdivgtltdivclassquotcsl-right-inlinequotstylequotmargin0.4em01.5emquotgtMcTagueAHowellKBCrossJHKurianMASchefferIE.Thegeneticlandscapeoftheepilepticencephalopathiesofinfancyandchildhood.TheLancetNeurologyInternet.2016Mar1cited2023Mar8153304x201316.Availablefromltaclass039zp-ItemURL039href039httpswww.thelancet.comjournalslaneurarticlePIIS1474-442228152900250-1fulltext039gthttpswww.thelancet.comjournalslaneurarticlePIIS1474-442228152900250-1fulltextltagtltdivgtnltdivgtnltdivgtdataitemTypejournalArticletitleThegeneticlandscapeoftheepilepticencephalopathiesofinfancyandchildhoodcreatorscreatorTypeauthorfirstNameAmylastNameMcTaguecreatorTypeauthorfirstNameKatherineB.lastNameHowellcreatorTypeauthorfirstNameJ.HelenlastNameCrosscreatorTypeauthorfirstNameManjuA.lastNameKuriancreatorTypeauthorfirstNameIngridE.lastNameSchefferabstractNotedate2016-03-01sectionpartNumberpartTitleDOI10.1016S1474-44221500250-1citationKeyurlhttpswww.thelancet.comjournalslaneurarticlePIIS1474-442228152900250-1fulltextPMID26597089PMCIDISSN1474-44221474-4465languageEnglishcollectionsFXKK8Z46dateModified2026-07-15T223954Z
1.
McTague A, Howell KB, Cross JH, Kurian MA, Scheffer IE. The genetic landscape of the epileptic encephalopathies of infancy and childhood. The Lancet Neurology [Internet]. 2016 Mar 1 [cited 2023 Mar 8];15(3):304–16. Available from: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422%2815%2900250-1/fulltext

19955111
{19955111:JDZMHR7Y}
1
vancouver
50
default
4930
https://neuropediatoolkit.org/wp-content/plugins/zotpress/
statussuccessupdateneededfalseinstancefalsemetarequest_last0request_next0used_cachetruedatakeyJDZMHR7Ylibraryid19955111metacreatorSummarySyrbeparsedDate2022-10-31numChildren1bibltdivclassquotcsl-bib-bodyquotstylequotline-height1.35quotgtnltdivclassquotcsl-entryquotstylequotclearleftquotgtnltdivclassquotcsl-left-marginquotstylequotfloatleftpadding-right0.5emtext-alignrightwidth1emquotgt1.ltdivgtltdivclassquotcsl-right-inlinequotstylequotmargin0.4em01.5emquotgtSyrbeS.Developmentalandepilepticencephalopathiesx2013therapeuticconsequencesofgenetictesting.MedizinischeGenetikInternet.2022Oct31cited2023Mar8343215x201324.Availablefromltaclass039zp-ItemURL039href039httpswww.degruyter.comdocumentdoi10.1515medgen-2022-2145html039gthttpswww.degruyter.comdocumentdoi10.1515medgen-2022-2145htmlltagtltdivgtnltdivgtnltdivgtdataitemTypejournalArticletitleDevelopmentalandepilepticencephalopathiesu2013therapeuticconsequencesofgenetictestingcreatorscreatorTypeauthorfirstNameSteffenlastNameSyrbeabstractNoteDevelopmentalandepilepticencephalopathiescompriseaheterogeneousgroupofmonogenicneurodevelopmentaldisorderscharacterizedbyearly-onsetseizuresmarkedepilepticactivityandabnormalneurocognitivedevelopment.Theidentificationofanincreasingnumberofunderlyinggeneticalterationsandtheirpathophysiologicalrolesincellularsignalingdrivesthewaytowardnovelprecisiontherapies.Theimplementationofnoveltreatmentsthattargettheunderlyingmechanismsgiveshopefordiseasemodificationthatwillimprovenotonlytheseizureburdenbutalsotheneurodevelopmentaloutcomeofaffectedchildren.Sofarbeneficialeffectsaremostlyreportedinindividualtrialsandsmallnumbersofpatients.Thereisaneedforinternationalcollaborativestudiestodefinethenaturalhistoryandrelevantoutcomemeasuresandtotestnovelpharmacologicalapproaches.date2022-10-31sectionpartNumberpartTitleDOI10.1515medgen-2022-2145citationKeyurlhttpswww.degruyter.comdocumentdoi10.1515medgen-2022-2145htmlPMIDPMCIDISSN1863-5490languageencollectionsFXKK8Z46dateModified2026-07-15T223818Z
1.
Syrbe S. Developmental and epileptic encephalopathies – therapeutic consequences of genetic testing. Medizinische Genetik [Internet]. 2022 Oct 31 [cited 2023 Mar 8];34(3):215–24. Available from: https://www.degruyter.com/document/doi/10.1515/medgen-2022-2145/html

19955111
{19955111:JDZMHR7Y}
1
vancouver
50
default
4930
https://neuropediatoolkit.org/wp-content/plugins/zotpress/
statussuccessupdateneededfalseinstancefalsemetarequest_last0request_next0used_cachetruedatakeyJDZMHR7Ylibraryid19955111metacreatorSummarySyrbeparsedDate2022-10-31numChildren1bibltdivclassquotcsl-bib-bodyquotstylequotline-height1.35quotgtnltdivclassquotcsl-entryquotstylequotclearleftquotgtnltdivclassquotcsl-left-marginquotstylequotfloatleftpadding-right0.5emtext-alignrightwidth1emquotgt1.ltdivgtltdivclassquotcsl-right-inlinequotstylequotmargin0.4em01.5emquotgtSyrbeS.Developmentalandepilepticencephalopathiesx2013therapeuticconsequencesofgenetictesting.MedizinischeGenetikInternet.2022Oct31cited2023Mar8343215x201324.Availablefromltaclass039zp-ItemURL039href039httpswww.degruyter.comdocumentdoi10.1515medgen-2022-2145html039gthttpswww.degruyter.comdocumentdoi10.1515medgen-2022-2145htmlltagtltdivgtnltdivgtnltdivgtdataitemTypejournalArticletitleDevelopmentalandepilepticencephalopathiesu2013therapeuticconsequencesofgenetictestingcreatorscreatorTypeauthorfirstNameSteffenlastNameSyrbeabstractNoteDevelopmentalandepilepticencephalopathiescompriseaheterogeneousgroupofmonogenicneurodevelopmentaldisorderscharacterizedbyearly-onsetseizuresmarkedepilepticactivityandabnormalneurocognitivedevelopment.Theidentificationofanincreasingnumberofunderlyinggeneticalterationsandtheirpathophysiologicalrolesincellularsignalingdrivesthewaytowardnovelprecisiontherapies.Theimplementationofnoveltreatmentsthattargettheunderlyingmechanismsgiveshopefordiseasemodificationthatwillimprovenotonlytheseizureburdenbutalsotheneurodevelopmentaloutcomeofaffectedchildren.Sofarbeneficialeffectsaremostlyreportedinindividualtrialsandsmallnumbersofpatients.Thereisaneedforinternationalcollaborativestudiestodefinethenaturalhistoryandrelevantoutcomemeasuresandtotestnovelpharmacologicalapproaches.date2022-10-31sectionpartNumberpartTitleDOI10.1515medgen-2022-2145citationKeyurlhttpswww.degruyter.comdocumentdoi10.1515medgen-2022-2145htmlPMIDPMCIDISSN1863-5490languageencollectionsFXKK8Z46dateModified2026-07-15T223818Z
1.
Syrbe S. Developmental and epileptic encephalopathies – therapeutic consequences of genetic testing. Medizinische Genetik [Internet]. 2022 Oct 31 [cited 2023 Mar 8];34(3):215–24. Available from: https://www.degruyter.com/document/doi/10.1515/medgen-2022-2145/html
